Drug Development of Therapeutic Monoclonal Antibodies
Drug Development of Therapeutic Monoclonal Antibodies
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Monoclonal antibodies (MAbs) have become a substantial part of many pharmaceutical company portfolios. However, the development process of MAbs for clinical use is quite different than for small-molecule drugs. MAb development programs require careful interdisciplinary evaluations to ensure the pharmacology of both the MAb and the target antigen ar...
Alternative Titles
Full title
Drug Development of Therapeutic Monoclonal Antibodies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1815710794
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1815710794
Other Identifiers
ISSN
1173-8804
E-ISSN
1179-190X
DOI
10.1007/s40259-016-0181-6
